Results 91 to 100 of about 26,238 (200)
Radiation-induced skin injury (RISI) is one of the most common complications of radiotherapy, severely compromising patients’ quality of life. However, no standardized treatment has yet been established.
Yinhui Wang +7 more
doaj +1 more source
Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands
Background Programmed cell death ligand 1 (PD-L1) plays a critical role in the tumor microenvironment and overexpression in several solid cancers has been reported. This was associated with a downregulation of the local immune response, specifically of T-
Fabian Krutzek +2 more
doaj +1 more source
YAP camera perspectives in radiopharmaceutical research
Yap camera is a new concept gamma camera based on a multiscystal of Yttrium Alluminium perovskite (YAP) coupled to a position sensitive photomultiplier (PSPMT). It provides spatial resolution of about (in some prototypes better than) 1 mm.
G De Vincentis +9 more
core
Radiopharmaceutical tracers for cardiac imaging
Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Nuclear myocardial perfusion imaging with either single-photon emission computed tomography or positron emission tomography has been used extensively to perform ...
756545 +19 more
core +1 more source
Terbium-149 production: a focus on yield and quality improvement towards preclinical application
Terbium-149 (T1/2 = 4.1 h, Eα = 3.98 MeV (16.7%), 28 µm range in tissue) is a radionuclide with potential for targeted alpha therapy. Due to the negligible emission of α-emitting daughter nuclides, toxicity to healthy tissue may be reduced in comparison ...
C. Favaretto +11 more
doaj +1 more source
Background/Objectives: The cell surface proteoglycan glypican-3 (GPC3) is reportedly overexpressed in hepatocellular carcinoma (HCC) tissues, but not in benign liver tissues, rendering this protein a potential target for radionuclide theranostic ...
Eva-Maria Burger +9 more
doaj +1 more source
The selection and optimization of therapies for cancer patients urgently need personalization. Portable point‐of‐care electronic biosensors emerge as a groundbreaking solution contributing to better decision‐making in precision oncology.
Trang‐Anh Nguyen‐Le +8 more
doaj +1 more source
Residual radiopharmaceutical activity in venous access devices during PET and SPECT imaging: a real-world clinical observational cohort study. [PDF]
Solem R, Al-Amiri N, Skarping I.
europepmc +1 more source
Tumour SUVmean and volume relates to its radiation absorbed dose. [PDF]
Kao YH.
europepmc +1 more source

